Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
The Congressional Budget Office (CBO) is calling for more research into the No Surprises Act to evaluate the law’s effect on heal | The nonpartisan office is seeking more information on the law’s impact on healthcare prices, network participation, ownership structures and more.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

A new ad campaign takes aim at the "misaligned incentives" in the No Surprises Act arbitration process, arguing they "create a…

The number of out-of-network billing disputes proceeding to arbitration continues to grow, much to the consternation of health…

Industry giant UnitedHealthcare is adding its voice to the chorus of insurers criticizing the current state of the No Surprises…

A payer-backed group has launched a campaign challenging a bill that would build on the No Surprises Act. | A payer-backed group…

AI health tech company Daffodil Health is rolling out a new platform aimed at supporting payers in managing the No Surprises Act…

A federal appeals court has tossed key methodology used to resolve out-of-network claims under the No Surprises Act. | A federal…